Opinions and use of neoadjuvant therapy for resectable, borderline resectable, and locally advanced pancreatic cancer: international survey and case-vignette study

Opinions and use of neoadjuvant therapy for resectable, borderline resectable, and locally advanced pancreatic cancer: international survey and case-vignette study

Abstract Background Several new treatment options have become available for pancreatic ductal adenocarcinoma (PDAC), but the support for their use for resectable, borderline resectable and locally advanced PDAC is unclear. Methods A survey was distributed to the members of the European-African Hepat...

Full description

Bibliographic Details
Main Authors: Stefan Heinrich, Marc Besselink, Markus Moehler, Jean-Luc van Laethem, Michel Ducreux, Peter Grimminger, Jens Mittler, Hauke Lang, Manfred P. Lutz, Mickael Lesurtel, on behalf of the Scientific and Research Committee of the E-AHPBA and the EORTC pancreas working group
Format: Article
Language:English
Published: BMC 2019-07-01
Series:BMC Cancer
Subjects:
Pancreatic cancer
PDAC
Neoadjuvant therapy
Defintions
Resectability
Survey
Online Access:http://link.springer.com/article/10.1186/s12885-019-5889-5

Internet

http://link.springer.com/article/10.1186/s12885-019-5889-5

Similar Items